Press release
Emerging Sub-Segments Transforming the Gouty Arthritis Market Landscape
Gouty Arthritis Market
Projected Growth and Market Size of the Gouty Arthritis Market
The gouty arthritis market is forecasted to reach $5.06 billion by 2030, growing at a compound annual growth rate (CAGR) of 6.4% during the period. This expansion is largely fueled by an aging global population, greater awareness of chronic diseases, enhanced approaches to preventive arthritis care, improved patient adherence to treatments, and the rise of personalized therapies for gout. Significant trends influencing growth include a rising number of hyperuricemia cases, increasing demand for sustained disease management strategies, the development of combination drug therapies, better adoption of advanced diagnostic imaging techniques, and the growth of lifestyle-focused disease control methods.
Download a free report of the gouty arthritis market report:
https://www.thebusinessresearchcompany.com/report/gouty-arthritis-global-market-report?utm_source=OpenPR&utm_medium=Paid&utm_campaign=Apr_PR
Key Factors Accelerating Growth in the Gouty Arthritis Market
One major driver of growth is the increasing prevalence of hyperuricemia, a condition closely linked to gout development. As more patients seek long-term management options, treatments that address both symptoms and underlying causes are gaining traction.
Another important factor is the improved availability and use of diagnostic imaging tools such as ultrasound and dual-energy CT scans, which help in earlier and more accurate detection of gouty arthritis. These advancements enable timely interventions, boosting treatment efficacy and patient outcomes.
Leading Companies Influencing the Gouty Arthritis Market Landscape
Several prominent firms dominate this market, including Horizon Therapeutics plc, Pfizer Inc., Takeda Pharmaceutical Company Limited, AbbVie Inc., Bayer AG, Bristol Myers Squibb, Novartis International AG, Eli Lilly and Company, Amgen Inc., Gilead Sciences Inc., AstraZeneca plc, GlaxoSmithKline plc, Teijin Pharma Ltd, Regeneron Pharmaceuticals Inc., Boehringer Ingelheim International GmbH, JW Pharmaceutical, Arthrosi Therapeutics Ltd, XORTX Therapeutics Inc, Atom Therapeutics Co Ltd, Olatec Therapeutics LLC, InventisBio Co Ltd, Shanton Pharma, Selecta Biosciences Inc, LG Chem Ltd, and Protalix BioTherapeutics Inc.
View the full gouty arthritis market report:
https://www.thebusinessresearchcompany.com/report/gouty-arthritis-global-market-report?utm_source=OpenPR&utm_medium=Paid&utm_campaign=Apr_PR
In a notable development from October 2023, Amgen Inc., a US-based biotechnology leader, acquired Horizon Therapeutics plc for $27.8 billion. This strategic acquisition aims to bolster Amgen's portfolio in rare diseases and inflammatory conditions, expanding its therapeutic offerings and enhancing revenue potential. Horizon Therapeutics plc, headquartered in Ireland, specializes in treatments specifically targeting gouty arthritis.
Recent Innovations Positively Impacting the Gouty Arthritis Market
Companies within the medical device and healthcare sectors are increasingly focusing on advanced health wearables designed for remote monitoring and personalized wellness management. These smart devices collect continuous biometric data, enabling users to track their health metrics in real time and make informed decisions to maintain wellness.
For example, in May 2025, WHOOP Inc., a US-based medical technology firm, introduced Whoop 5.0 and Whoop MG-next-generation health wearables offering continuous, medical-grade monitoring capabilities. Features include on-demand ECGs, blood pressure tracking, hormonal analysis, and sophisticated recovery insights. These devices operate within a tiered subscription model (Whoop One, Peak, and Life), blending fitness tracking with clinical health assessment to support early detection and proactive health management.
Market Segmentation Highlighting the Leading Gouty Arthritis Categories
The gouty arthritis market is segmented into several key categories:
1) By Type: Acute Gouty Arthritis and Chronic Gouty Arthritis
2) By Treatment: Non-Steroidal Anti-Inflammatory Drugs (NSAIDs), Pain Relievers, Corticosteroids, Xanthine Oxidase Inhibitors, Uricosurics, and Other Treatments
3) By Diagnosis: Joint Fluid Test, Blood Test, X-Ray Imaging, Ultrasound, Dual Energy Computed Tomography (CT) Scan, and Other Diagnostic Methods
4) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, and Other Channels
5) By End-User: Hospitals, Specialty Clinics, and Other Users
Further breakdowns within these segments include:
- Acute Gouty Arthritis subtypes such as Monosodium Urate Crystals-Induced Acute Gout, Acute Gout Attack with intermittent flare-ups, and Severe Acute Gout accompanied by joint deformities.
- Chronic Gouty Arthritis subcategories including Tophaceous Gout (marked by uric acid deposits), Chronic Gout with joint damage, Chronic Gout with renal complications, and Chronic Gout with comorbidities like hypertension and diabetes.
This detailed segmentation allows for targeted treatment development and improved patient care strategies within the gouty arthritis landscape.
Reach out to us:
The Business Research Company: https://www.thebusinessresearchcompany.com/,
Americas +1 310-496-7795,
Europe +44 7882 955267,
Asia & Others +44 7882 955267 & +91 8897263534,
Email us at info@tbrc.info.
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Learn More About The Business Research Company
With over 17500+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Emerging Sub-Segments Transforming the Gouty Arthritis Market Landscape here
News-ID: 4479365 • Views: …
More Releases from The Business Research Company
Sequencing Reagents Market Analysis Highlights Growth To $24.46 Billion By 2030 …
The sequencing reagents market is set to undergo remarkable growth in the coming years, driven by advances in technology and expanding applications. As innovations continue to emerge, this sector is becoming increasingly vital in the fields of genomics, personalized medicine, and biopharmaceutical research. Let's explore the current market outlook, key players, emerging trends, and the main segments shaping the future of sequencing reagents.
Forecasted Growth Trajectory of the Sequencing Reagents Market…
Sensory Rooms Market Study Highlights How Industry Demand Is Evolving
The sensory rooms industry is emerging as a rapidly growing sector, driven by increasing demand for specialized therapeutic environments that support mental wellness and sensory needs. With innovations in technology and a rising focus on inclusivity, this market is poised to experience substantial expansion over the coming years. Below is an overview of the market size, key players, trends, and segmentation within the sensory rooms landscape.
Projected Market Size and Growth…
Semi-Solid Dosage Contract Manufacturing Market Research Reveals Strong 10.4% CA …
The semi-solid dosage contract manufacturing market is set for impressive expansion in the coming years, driven by evolving pharmaceutical and cosmeceutical needs. As demand grows for specialized topical treatments and sustainable manufacturing practices, this sector is poised to transform significantly. Let's explore the current market size, key players, notable trends, and segmentation details shaping this dynamic industry.
Projected Growth Trajectory of the Semi-Solid Dosage Contract Manufacturing Market
The semi-solid dosage…
Self-Administered Parenteral Market Intelligence Report Covers Trends, Segments …
The self-administered parenteral market is steadily gaining traction as advancements in technology and patient-centric healthcare approaches continue to evolve. With innovations enhancing convenience and effectiveness, this sector is set to offer new treatment possibilities that empower patients to manage their therapies more independently. Let's explore the market's current valuation, key contributors, driving forces, and the major segments shaping its future.
Expected Market Size and Growth Trajectory for the Self-Administered Parenteral Market…
More Releases for Gout
Gout Disease Treatment Market Progress: Advancing Long-Term Care for Chronic Gou …
The global Gout Disease Treatment Market is witnessing sustained growth as healthcare systems place greater emphasis on the early diagnosis and long-term management of gout. As one of the most prevalent inflammatory arthritis conditions worldwide, gout requires continuous treatment to control uric acid levels, prevent recurrent flare-ups, and minimize long-term joint damage. Advances in treatment protocols, increasing patient awareness, and improved access to healthcare services are collectively driving the adoption…
Chronic Gout Market Trends, Therapeutics, and Growth Opportunities
Chronic gout is a progressive form of arthritis characterized by elevated uric acid levels, leading to severe joint pain, inflammation, and long-term joint damage. This condition affects millions worldwide, often resulting in impaired mobility and reduced quality of life. With rising prevalence due to lifestyle changes, aging populations, and dietary habits, the Chronic Gout market is witnessing a surge in demand for advanced therapeutics, early diagnostics, and patient management solutions.
Download…
Chronic Gout Market Massive Growth opportunity Ahead
Introduction
Chronic gout is a form of arthritis characterized by recurrent attacks of severe pain, swelling, and inflammation in the joints, often due to the accumulation of uric acid crystals. This condition typically affects the big toe but can also impact other joints, including the knees, elbows, and wrists. Uric acid, a by-product of purine metabolism, accumulates in the body due to overproduction or underexcretion by the kidneys, leading to hyperuricemia…
Gout Market Innovations in Pain Management and Treatment
On April 08, 2025, Exactitude Consultancy., Ltd. announces the release of the report "Global Gout Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2034". The report is a detailed and comprehensive analysis presented by region and country, type and application. As the market is constantly changing, the report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many…
Gout Therapeutics Market Analysis By Drug Class (Nonsteroidal Anti-inflammatory …
Report Summary
The global gout therapeutics market was valued at USD 2.78 Billion in 2021 and is expected to grow at a CAGR of 13.7% during the forecast period 2023-2032.
Gout Therapeutics Market Introduction
The deposition of monosodium crystals (MSU) into the distal joints and peripheral tissues results in gout, an inflammatory arthritic disease. Gout is a typical type of painful inflammatory arthritis. One joint is typically affected at a time (often…
Global Gout Drugs Market Analysis (2020-2025)
Global Info Research offers a latest published report on Gout Drugs Analysis and Forecast 2020-2025 delivering key insights and providing a competitive advantage to clients through a detailed report. This report focuses on the key global Gout Drugs Concentrate players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years.
Click to view the full report TOC, figure and tables:
https://www.globalinforesearch.com/reports/371311/gout-drugs
Market…
